We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VIA:NYSEVia Transportation, Inc. Analysis

Data as of 2026-05-09 - not real-time

$17.31

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Via Transportation’s stock is trading at $17.31, just above its computed support of $14.42 and below a resistance of $18.77, with the 20‑day SMA ($16.56) and 50‑day SMA ($16.23) both under the current price, indicating a modest upside cushion. The RSI of 55.6 suggests the stock is neither overbought nor oversold, while a bullish MACD histogram (+0.21) and increasing volume point to short‑term buying pressure. However, volatility is extremely high at nearly 70% over the past 30 days and a beta of 1.25 signals amplified market swings. Fundamentally, the company is struggling: revenue grew 29.7% year‑over‑year but operating and profit margins remain deeply negative (‑20.5% and ‑22.2%), cash flow is negative, and free cash flow is a deficit of $11.8 M. The balance sheet shows a high debt‑to‑equity ratio of 3.0, and the forward PE of 29.5 is well below the industry average of 38.5, hinting at a valuation discount despite weak earnings. Material news highlights multiple securities‑fraud investigations by law firms, adding significant regulatory and reputational risk. The upcoming Q1 2026 earnings release could provide clarity, but the combination of financial distress and legal scrutiny makes the near‑term outlook fragile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Proximity to technical support level
  • Ongoing securities‑fraud investigations
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth and AI‑driven product pipeline
  • Continued cash burn and negative earnings
  • Resolution of regulatory investigations

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Forward earnings potential (positive forward EPS)
  • Undervalued forward PE relative to industry
  • Potential market expansion in transit‑tech platforms

Key Metrics & Analysis

Financial Health

Revenue Growth29.70%
Profit Margin-22.19%
P/E Ratio29.5
ROE-23.08%
ROA-8.61%
Debt/Equity3.05
P/B Ratio2.2
Op. Cash Flow$-30869000
Free Cash Flow$-11795375
Industry P/E38.4

Technical Analysis

TrendNeutral
RSI55.6
Support$14.42
Resistance$18.77
MA 20$16.56
MA 50$16.23
MA 200$29.95
MACDBullish
VolumeIncreasing
Fear & Greed Index90.73

Valuation

Target Price$33.70
Upside/Downside94.69%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.25
Volatility69.80%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.